TULUP (TUnisian LUPus): a multicentric study of systemic lupus erythematosus in Tunisia

被引:26
作者
Khanfir, Monia Smiti [1 ,2 ]
Houman, Mohamed Habib [1 ,2 ]
Cherif, Eya [2 ,3 ]
Hamzaoui, Amira [1 ,2 ]
Souissi, Sonia [4 ]
Ben Ghorbel, Imed [1 ,2 ]
Ksontini, Imene [2 ,5 ]
Braham, Amel [1 ,2 ]
机构
[1] La Rabta Univ Hosp, Dept Internal Med, Tunis 1007, Tunisia
[2] Tunisian Soc Internal Med, Tunis, Tunisia
[3] Charles Nicolle Univ Hosp, Dept Internal Med, Tunis, Tunisia
[4] Fac Med Tunis, Dept Prevent Med, Tunis, Tunisia
[5] FSI Univ Hosp, Dept Internal Med, La Marsa, Tunisia
关键词
epidemiology; ethnicity; geographic distribution; systemic lupus erythematosus; CLINICAL ASSOCIATIONS; COHORT; PHOTOSENSITIVITY; AUTOANTIBODIES; MANIFESTATIONS; CLASSIFICATION; EPIDEMIOLOGY; SPECTRUM; PATTERNS; FEATURES;
D O I
10.1111/1756-185X.12152
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AimClinical features of systemic lupus erythematosus (SLE) have been described from different geographical regions around the world. However, data from North African countries, including Tunisia, are scarce. MethodsThe aim of this retrospective multicenter study was to analyze demographic, clinical, laboratory features and outcome of SLE in Tunisia throughout 14 Departments of Internal Medicine and to compare them with those of other ethnic and geographic groups. ResultsSeven hundred and forty-nine cases of SLE were recorded (American College of Rheumatology criteria) during a 17-year period (1989-2006). They were 676 women and 73 men with an average age at SLE onset of approximately 30.66years. Our Tunisian patients were characterized by a high frequency of photosensitivity (67.6%), malar rash (68.7%), renal involvement (49.5%) and anti-Sm antibodies (44.8%). Infections were the main complications. Fifty-six (7.5%) patients died during the study period. ConclusionPotential limitations and biases in our study need discussion. Specific recruitment of patients in tertiary referral centers may be the source of selection bias and adding to the frequency of moderate or even severe diseases. The therapeutic management and outcome monitoring were heterogeneous due to the fact that patients were evaluated by different doctors. However, this study remains the most representative of Tunisian SLE patientsrecruited from all parts of Tunisia.
引用
收藏
页码:539 / 546
页数:8
相关论文
共 31 条
  • [1] Systemic lupus erythematosus in Kuwait - hospital based study
    Al-Jarallah, K
    Al-Awadi, A
    Siddiqui, H
    Al-Salim, I
    Shehab, D
    Umamaheswaran, I
    Gaurer, S
    Al-Saied, K
    Kumar, R
    Malaviya, AN
    [J]. LUPUS, 1998, 7 (07) : 434 - 438
  • [2] Systemic lupus erythematosus in three ethnic groups:: III A comparison of characteristics early in the natural history of the LUMINA cohort
    Alarcón, GS
    Friedman, AW
    Straaton, KV
    Moulds, JM
    Lisse, J
    Bastian, HM
    McGwin, G
    Bartolucci, AA
    Roseman, JM
    Reveille, JD
    [J]. LUPUS, 1999, 8 (03) : 197 - 209
  • [3] SYSTEMIC LUPUS-ERYTHEMATOSUS IN SAUDI PATIENTS
    ALBALLA, SR
    [J]. CLINICAL RHEUMATOLOGY, 1995, 14 (03) : 342 - 346
  • [4] American Rheumatism Association Glossary Committee, 1982, SIGNS SYMPT, V1, P1
  • [5] DERIVATION OF THE SLEDAI - A DISEASE-ACTIVITY INDEX FOR LUPUS PATIENTS
    BOMBARDIER, C
    GLADMAN, DD
    UROWITZ, MB
    CARON, D
    CHANG, CH
    [J]. ARTHRITIS AND RHEUMATISM, 1992, 35 (06): : 630 - 640
  • [6] SYSTEMIC LUPUS-ERYTHEMATOSUS - CLINICAL AND IMMUNOLOGICAL PATTERNS OF DISEASE EXPRESSION IN A COHORT OF 1,000 PATIENTS
    CERVERA, R
    KHAMASHTA, MA
    FONT, J
    SEBASTIANI, GD
    GIL, A
    LAVILLA, P
    DOMENECH, I
    AYDINTUG, AO
    JEDRYKAGORAL, A
    DERAMON, E
    GALEAZZI, M
    HAGA, HJ
    MATHIEU, A
    HOUSSIAU, F
    INGELMO, M
    HUGHES, GRV
    CERVERA, R
    SEBASTIANI, GD
    FONT, J
    KHAMASHTA, MA
    HUGHES, GRV
    FONT, J
    CERVERA, R
    LOPEZSOTO, A
    VIVANCOS, J
    INGELMO, M
    URBANOMARQUEZ, A
    KHAMASHTA, MA
    VIANNA, J
    HUGHES, GRV
    GIL, A
    LAVILLA, P
    PINTADO, V
    LOPEZDUPLA, M
    VAZQUEZ, JJ
    SEBASTIANI, GD
    DERAMON, E
    CAMPS, M
    FRUTOS, MA
    PERELLO, I
    SANTOS, PG
    ABARCA, M
    NEBRO, AF
    DOMENECH, I
    TOKGOZ, G
    AYDINTUG, AO
    JEDRYKAGORAL, A
    MALDYKOWA, H
    CHWALINSKASADOWSKA, H
    GALEAZZI, M
    [J]. MEDICINE, 1993, 72 (02) : 113 - 124
  • [7] Chien J W, 2001, Zhonghua Yi Xue Za Zhi (Taipei), V64, P283
  • [8] TAP1 and TAP2 polymorphisms analysis in northwestern Colombian patients with systemic lupus erythematosus
    Correa, PA
    Molina, JF
    Pinto, LF
    Arcos-Burgos, M
    Herrera, M
    Anaya, JM
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (04) : 363 - 365
  • [9] Clinical and serological characteristics in 128 patients with systemic lupus erythematosus
    Ghedira, I
    Sakly, W
    Jeddi, M
    [J]. PATHOLOGIE BIOLOGIE, 2002, 50 (01): : 18 - 24
  • [10] Habib GS, 2002, ISRAEL MED ASSOC J, V4, P690